Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Plethico Pharma Defers Entry Into US Nutraceutical Market
According to industry estimates the US market grew by a meagre 1-2% in 2009, in contrast to the 14-15% growth witnessed in emerging markets in Latin America, Asia,
According to industry estimates the US market grew by a meagre 1-2% in 2009, in contrast to the 14-15% growth witnessed in emerging markets in Latin America, Asia,
In keeping with the streamlining focus of Oystar’s recent realignment strategy, Packaging Technologies and Aerofill Dawson will consolidate their operations into the Davenport, Iowa-based 200,000 square-foot facility. As
Reportedly, Arena has submitted Lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The
The randomised, controlled, open-label Phase 3 trial, conducted under a Special Protocol Assessment (SPA) and Fast Track designation, had enrolled 903 patients with Stage IIIb/IV NSCLC, which includes
The move positions Community Research to offer clinical trials to US sponsors with a combination of safety (the hospital-based clinical research unit) and independence (privately owned and operated
AutoGenomics has developed the automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with genomic and proteomic markers in the area of genetic
Pantec said that although smaller peptides and some proteins have previously been delivered transdermally, this is the first time a molecule as large as this protein (32 KDa)
Brenntag said that the new warehouse in Thailand enables it to separate storage of pharmaceutical as well as food products. Reportedly, the Brenntag team composed of 15 employees
Prevnar 13 is indicated for active immunization of children 6 weeks through 5 years of age for the prevention of invasive disease caused by 13 Streptococcus pneumoniae (S
The Ion PGM Sequencer Grant Program was designed to foster the development of new applications for DNA sequencing that leverage the instrument’s speed, scalability and low cost. The